Hair loss and graying, the earliest visible hallmarks of skin aging, result from the functional decline of hair follicle stem cells (HFSCs) and their niche. Dr. Zhao and colleagues conducted a comprehensive analysis of human scalp samples using single-cell RNA sequencing (11 samples, 57,181 cells in total) and spatial transcriptomics (1 sample) to detail the mechanisms involved. The study confirmed the transitional stages of three mitotic keratinocyte subtypes. Comparison of middle-aged and young scalps revealed three key age-associated changes: activated AP-1 transcription factor complex in keratinocytes; up-regulated DCT gene in melanocytes; and a dramatic decrease in BMP and non-canonical WNT (ncWNT) signaling within the critical dermal papilla-keratinocyte crosstalk. This breakdown of essential inter-cellular communication and activation of stress signals provides valuable, cell-resolved insights into hair follicle aging, supporting the development of future regenerative therapies targeting these pathways.

The fungal species Candida auris is spreading across the globe, and gaining in virulence - but there are strategies available and underway to combat the invasive and drug resistant germ, according to a new review by a Hackensack Meridian Center for Discovery and Innovation (CDI) scientist and colleagues. 

A new ‘biomimetic’ model of brain circuits and function at multiple scales produced naturalistic dynamics and learning, and even identified curious behavior by some neurons that had gone unnoticed in real-brain data

Understanding how cells decide their fate is a central challenge in biology, complicated by the fact that single-cell RNA sequencing captures only static snapshots of highly complex and dynamic changes in cell state. In a recent study, researchers from Japan developed a computational method, called ddHodge, that can accurately reconstruct cell state dynamics, shedding light on how genes drive cell fate decisions. Their technique could be useful in developmental biology, regenerative medicine, and cancer research.

Intestinal Stem Cells (ISCs) derived from a patient's own cells have garnered significant attention as a new alternative for treating intractable intestinal diseases due to their low risk of rejection. However, clinical application has been limited by safety and regulatory issues arising from conventional culture methods that rely on animal-derived components (xenogeneic components). A KAIST research team has developed an advanced culture technology that stably grows ISCs without animal components while simultaneously enhancing their migration to damaged tissues and regenerative capabilities.

China has moved from patchy, post-crisis biosafety rules to a unified legal regime anchored by the 2020 Biosecurity Law, yet fragmentation, weak risk intelligence and poor inter-agency coordination still leave gaps that could be exploited by novel pathogens, synthetic biology or geopolitical tension.  Historical review shows three phases: 1949-2002 built basic disease reporting and plant-quarantine systems but relied on paper records; 2003-2019 introduced internet-based surveillance, BSL-3/4 laboratories and alignment with WHO’s International Health Regulations after the SARS shock; 2020-present elevated biosafety to national-security status, enacted the Biosecurity Law and poured funds into diagnostics, vaccines and bio-economic R&D during COVID-19.  These steps created the skeleton of a modern system, but four structural weaknesses persist: strategic plans lack operational road-maps and AI-enabled foresight; the legal framework offers no clear dispute-resolution or accountability mechanisms; organisational silos among health, agriculture, science and military agencies hamper horizontal coordination; and public awareness plus professional training remain patchy, weakening compliance culture.

The integration of PD-1 inhibitors into standard chemotherapy and radiotherapy regimens has revolutionized nasopharyngeal carcinoma treatment, yet only a minority of patients achieve durable responses, creating an urgent need for reliable biomarkers that can predict immunotherapy benefit. Recent investigations have identified multiple candidate predictors spanning both the tumor microenvironment and macroenvironment, ranging from tumor-intrinsic factors like PD-L1 expression and Epstein-Barr virus DNA levels to systemic indicators including peripheral blood cell counts and circulating cytokines. These biomarkers reflect the complex interplay between tumor biology, host immunity, and environmental factors that ultimately determine treatment outcomes.